Articles by Daniel Marsh
Veradermics Soars After Hair-Loss Drug Meets Trial Goals
Veradermics shares jumped 40% after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial, with patients seeing significant hair count increases.
HTCO Shares Surge Over 230% on Lithium Transport Expansion Plans
High-Trend International Group shares surged over 233% to $37.51 on Nasdaq Monday, with trading volume spiking to 10.09 million shares, as the company announced plans to double lithium-related shipments in 2026.
ARC Resources Surges After Shell's $16.4B Montney Acquisition
Shell acquires ARC Resources for $16.4 billion, sending ARC shares up over 22% and signaling major confidence in the Montney shale basin.
Sandisk Hits Record High on AI Memory Optimism Ahead of Earnings
Sandisk surged 7.4% to a record $1,063.55 on Monday after Melius Research started coverage with a Buy rating and $1,350 target, as AI-driven memory demand fuels bullish sentiment ahead of earnings.
Wren Kitchens' US Arm Files Chapter 7, Leaving Customers and Staff in Limbo
Wren Kitchens' US parent filed Chapter 7 bankruptcy, abruptly closing all US showrooms and leaving customers with unfinished orders and employees without notice.
RTX Downgraded to Hold After 11% Drop Despite Strong Earnings
RTX stock was downgraded to hold by Erste Group after an 11% drop, despite strong Q1 earnings and a raised 2026 outlook. Tariff costs and valuation concerns continue to pressure shares.





